The top 20 targets with larger weight are ESR1, IL2, IL1B, TLR9, and ACE, etc. Interestingly, majority of these targets are related to immunity and inflammation, which are confirmed associated with the pathogenesis of SLE and that maybe indicate potential therapeutic mechanisms of LCW on SLE. This evidence concerns the gene IL1B and systemic lupus erythematosus.